Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-12 Dier Mardi CFO & Executive Vice President Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-10-08 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion +10,000 $54.50 $545K 34,293
2020-10-08 Parschauer Karah Herdman EVP and General Counsel Sale −10,000 $95.00 $950K 24,293
2020-10-08 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion · Stock Option (Right to Buy) −10,000 35,000
2020-10-06 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion +10,000 $48.43 $484K 34,293
2020-10-06 Parschauer Karah Herdman EVP and General Counsel Sale −10,000 $90.00 $900K 24,293
2020-10-06 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion · Stock Option (Right to Buy) −10,000 17,000
2020-09-23 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion +10,000 $48.43 $484K 34,293
2020-09-23 Parschauer Karah Herdman EVP and General Counsel Sale −10,000 $85.00 $850K 24,293
2020-09-23 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion · Stock Option (Right to Buy) −10,000 27,000
2020-09-01 KAKKIS EMIL D President & CEO Sale −30,000 $82.63 $2.5M 2,389,741
2020-08-21 Aliski William Director Exercise or conversion +5,000 $58.74 $294K 62,018
2020-08-21 Aliski William Director Sale −5,000 $86.57 $433K 57,018
2020-08-21 Aliski William Director Exercise or conversion · Stock Option (Right to Buy) −5,000 0
2020-08-17 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion +10,000 $54.50 $545K 36,663
2020-08-17 Parschauer Karah Herdman EVP and General Counsel Sale −10,000 $88.44 $884K 26,663
2020-08-17 Parschauer Karah Herdman EVP and General Counsel Sale −2,370 $88.39 $209K 24,293
2020-08-17 Parschauer Karah Herdman EVP and General Counsel Exercise or conversion · Stock Option (Right to Buy) −10,000 45,000
2020-08-17 Sharp Shalini CFO & Executive Vice President Sale −461 $88.24 $41K 100,747
2020-08-17 Sharp Shalini CFO & Executive Vice President Sale −2,560 $88.54 $227K 98,187

Page 24 of 32 · 632 trades